多基因风险评分在复杂性状疾病中的应用进展

摘要/Abstract

中图分类号:

R596

吴歆, 耿旭强, 徐沪济. 多基因风险评分在复杂性状疾病中的应用进展[J]. 诊断学理论与实践, 2020, 19(05): 540-543.

图/表2

表1

近5年PubMed数据库中关键词为“PRS”加“疾病名”的文献数量

疾病分类	研究相对集中的代表性疾病	文献数量（篇）
心血管疾病	冠心病	5
	房颤	5
肿瘤性疾病	肺癌	1
	乳腺癌	57
精神性疾病	精神分裂症	164
	双向情感障碍	55
	孤独症	20
自身免疫病	RA	4
	炎症性肠病	2
内分泌疾病	糖尿病	49

表1

图1

参考文献25

[1]	Mistry S, Harrison JR, Smith DJ, et al. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: a systema-tic review[J]. J Affect Disord, 2018, 234:148-155. doi:10.1016/j.jad.2018.02.005 URL
[2]	Mega JL, Stitziel NO, Smith JG, et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials[J]. Lancet, 2015, 385(9984):2264-2271. doi:10.1016/S0140-6736(14)61730-Xpmid:25748612
[3]	Tada H, Melander O, Louie JZ, et al. Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history[J]. Eur Heart J, 2016, 37(6):561-567. doi:10.1093/eurheartj/ehv462 URL
[4]	Natarajan P, Young R, Stitziel NO, et al. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting[J]. Circulation, 2017, 135(22):2091-2101. doi:10.1161/CIRCULATIONAHA.116.024436pmid:28223407
[5]	Khera AV, Emdin CA, Drake I, et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease[J]. N Engl J Med, 2016, 375(24):2349-2358. doi:10.1056/NEJMoa1605086 URL
[6]	Xu Z, Liu H, Sun C, et al. Association between a genetic risk score based on single nucleotide polymorphisms of coronary artery disease-related genes and left main coronary artery disease[J]. Biomed Res Int, 2018, 2018:8610368.
[7]	Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations[J]. Nat Genet, 2018, 50(9):1219-1224. doi:10.1038/s41588-018-0183-zpmid:30104762
[8]	韩俊庆. 临床肿瘤学指南[M]. 山东科学技术出版社, 2016.
[9]	Markham MJ, Wachter K, Agarwal N, et al. Clinical Cancer Advances 2020: annual report on progress against cancer from the American Society of Clinical Oncology[J]. J Clin Oncol, 2020, 38(10):1081.
[10]	Dai J, Lv J, Zhu M, et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations[J]. Lancet Respir Med, 2019, 7(10):881-891. doi:10.1016/S2213-2600(19)30144-4 URL
[11]	van Veen EM, Brentnall AR, Byers H, et al. Use of single-nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction[J]. JAMA Oncol, 2018, 4(4):476-482. doi:10.1001/jamaoncol.2017.4881 URL
[12]	Läll K, Lepamets M, Palover M, et al. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification[J]. BMC Cancer, 2019, 19(1):557. doi:10.1186/s12885-019-5783-1 URL
[13]	Palmer JR. Polygenic risk scores for breast cancer risk prediction: lessons learned and future opportunities[J]. J Natl Cancer Inst, 2020, 112(6):555-556. doi:10.1093/jnci/djz176pmid:31553456
[14]	Wen W, Shu XO, Guo X, et al. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry[J]. Breast Cancer Res, 2016, 18(1):124. doi:10.1186/s13058-016-0786-1 URL
[15]	Wang Z, Liu Q, Wilson CL, et al. Polygenic determinants for subsequent breast cancer risk in survivors of childhood cancer: the St Jude Lifetime Cohort Study (SJLIFE)[J]. Clin Cancer Res, 2018, 24(24):6230-6235. doi:10.1158/1078-0432.CCR-18-1775 URL
[16]	Lencz T, Knowles E, Davies G, et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium(COGENT)[J]. Mol Psychiatry, 2014, 19(2):168-174. doi:10.1038/mp.2013.166 URL
[17]	Hubbard L, Tansey KE, Rai D, et al. Evidence of common genetic overlap between schizophrenia and cognition[J]. Schizophr Bull, 2016, 42(3):832-842. doi:10.1093/schbul/sbv168pmid:26678674
[18]	Córdova-Palomera A, Kaufmann T, Bettella F, et al. Effects of autozygosity and schizophrenia polygenic risk on cognitive and brain developmental trajectories[J]. Eur J Hum Genet, 2018, 26(7):1049-1059. doi:10.1038/s41431-018-0134-2pmid:29700391
[19]	Mallet J, Le Strat Y, Dubertret C, et al. Polygenic risk scores shed light on the relationship between schizophrenia and cognitive functioning: review and meta-analysis[J]. J Clin Med, 2020, 9(2):341. doi:10.3390/jcm9020341 URL
[20]	Hettige NC, Cole CB, Khalid S, et al. Polygenic risk score prediction of antipsychotic dosage in schizophrenia[J]. Schizophr Res, 2016, 170(2-3):265-270. doi:10.1016/j.schres.2015.12.015pmid:26778674
[21]	Jones HJ, Hubbard L, Mitchell RE, et al. Association of genetic risk for rheumatoid arthritis with cognitive and psychiatric phenotypes across childhood and adolescence[J]. JAMA Netw Open, 2019, 2(6):e196118.
[22]	Ge T, Chen CY, Ni Y, et al. Polygenic predictionviaBayesian regression and continuous shrinkage priors[J]. Nat Commun, 2019, 10(1):1776. doi:10.1038/s41467-019-09718-5 URL
[23]	Khan MAB, Hashim MJ, King JK, et al. Epidemiology of type 2 diabetes-global burden of disease and forecasted trends[J]. J Epidemiol Glob Health, 2020, 10(1):107-111. doi:10.2991/jegh.k.191028.001 URL
[24]	Oram RA, Patel K, Hill A, et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults[J]. Diabetes Care, 2016, 39(3):337-344. doi:10.2337/dc15-1111 URL
[25]	Padilla-Martínez F, Collin F, Kwasniewski M, et al. Systematic review of polygenic risk scores for type 1 and type 2 diabetes[J]. Int J Mol Sci, 2020, 21(5):1703. doi:10.3390/ijms21051703 URL

多基因风险评分在复杂性状疾病中的应用进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表2

参考文献25

相关文章15

编辑推荐

Metrics

本文评价

[1]	孙艳艳, 兰信堂.肺癌颅脑转移患者接受放射治疗后前庭功能受损1例[J]. 诊断学理论与实践, 2022, 21(05): 632-634.
[2]	李佳, 吕良敬.靶向治疗时代议自身免疫病的感染挑战[J]. 诊断学理论与实践, 2022, 21(03): 299-303.
[3]	陆弘逾, 顾俊, 王静, 曹亚峰, 宋陆茜, 范俊, 陈梅.干燥综合征继发隐球菌性脑膜脑炎一例报告及相关自身免疫病文献复习[J]. 诊断学理论与实践, 2021, 20(05): 456-461.
[4]	施仲伟.回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读[J]. 诊断学理论与实践, 2021, 20(04): 349-355.
[5]	杜海磊, 陈聆, 罗方秀, 李勇, 程齐俭, 朱良纲, 杭钧彪.Beclin-1和Bcl-2表达与非小细胞肺癌患者病理特征及预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 258-263.
[6]	倪瀚文, 吴立群.外泌体在心肌缺血及房颤诊治中的应用前景研究进展[J]. 诊断学理论与实践, 2020, 19(02): 199-202.
[7]	陈瑶瑶, 顾爱华.氧化三甲胺与心血管疾病关系的研究进展[J]. 诊断学理论与实践, 2019, 18(2): 237-240.
[8]	王晓妍, 潘丽娜, 高蓓莉, 徐志红, 胡家安.影像组学及影像基因组学在肺癌诊疗中的应用进展[J]. 诊断学理论与实践, 2019, 18(06): 711-714.
[9]	刘海霞, 瞿介明.肺部微生态及其与肺癌关系的研究进展[J]. 诊断学理论与实践, 2019, 18(05): 496-502.
[10]	王晓斐, 高蓓莉.肺癌免疫治疗标志物研究进展认识[J]. 诊断学理论与实践, 2018, 17(05): 494-498.
[11]	张国桢, 蔡庆, 张伟强.早期微小肺腺癌CT影像与病理的相关性[J]. 诊断学理论与实践, 2018, 17(05): 490-493.
[12]	韩宝惠, 沈胤晨.我国肺癌筛查现状与展望[J]. 诊断学理论与实践, 2018, 17(05): 487-489.
[13]	顾圣佳, 曹琪琪, 严福华, 杨文洁.双能CT在非小细胞肺癌非手术治疗疗效评估中的应用价值[J]. 诊断学理论与实践, 2018, 17(05): 526-532.
[14]	张新, 张新宇.支气管冲洗液基因检测在肺癌诊治中的价值[J]. 诊断学理论与实践, 2018, 17(05): 508-511.
[15]	马韵芳, 潘丽娜, 张培培, 何清, 徐志红, 胡家安.人类表皮生长因子受体2基因扩增的非小细胞肺癌一例报告[J]. 诊断学理论与实践, 2018, 17(04): 462-465.